GlassScriptPhysician profile
Jamie B Larson
NPI 1184960395
$9,613.79
in general payments reported to CMS, 2019-2025
43 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,480 · 2022: $1,725 · 2023: $2,284 · 2024: $2,105 · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,310 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,309.73 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,562.06 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,452.02 | 2021-2025 | Farxiga, Airsupra, Fasenra |
| Abbvie INC. | $842.16 | 2021-2025 | |
| Amgen INC. | $763.87 | 2021-2025 | Otezla, Repatha, Otezla |
| Glaxosmithkline, LLC. | $761.74 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $760.30 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.29 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $473.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $462.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $240.23 | 2022-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.92 | 2023-2025 | Xifaxan, Trulance |
| Dynavax Technologies Corporation | $124.93 | 2023-2025 | Heplisav-B |
| Teva Pharmaceuticals USA, INC. | $120.07 | 2021-2025 | Austedo Xr, Austedo Xr, Airduo Digihaler |
| Bausch Health US, LLC | $114.96 | 2021-2023 | Aplenzin |
| Abbott Laboratories | $110.51 | 2022-2023 | Freestyle Libre 3 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.